Skip to content
★ Sign in to follow
HV

Herbert Virgin

Executive
Executive Vice President and Chief Scientific Officer
Total declarations
130
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (62 ops.)
€9.9M

Latest filing published 10 Aug 2022 for Vir Biotechnology, Inc., €81k.

Filing timeline

BuySale
Herbert Virgin

Insider track record

Disclosed buys
0
Disclosed sells
62
Signal history

Herbert Virgin: trading record in brief

All filings by Herbert Virgin on record concern Vir Biotechnology, Inc., in the capacity of senior executive. Over a trading history stretching from 14 May 2020 to 9 August 2022, the count stands at 130 filings.

Sales make up the whole of the open-market record (62 sales, €9.9M). Other entries cover 2 share grants and 66 option exercises. 2022 to date brings no purchases and 5 sales.

Most recently, on 10 August 2022, the filings show an option exercise worth €81k in Vir Biotechnology, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Herbert Virgin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations129 total

25 of 129 declarations